Abstract
Bartonella henselae is the causative agent of cat-scratch disease and other disorders, including hepatosplenic granulomatosis. This infection has only rarely been reported after solid organ transplantation, where it can mimic the more common post-transplant lymphoproliferative disease. Here we present a case of asymptomatic B. henselae hepatic and lymph nodal granulomatosis in a pediatric patient who had received orthotopic liver transplant 2 months before; we hypothesize that the causative agent was transmitted from the donor. This infection developed early in the post-transplant period; the disease involved only the graft liver and the regional lymph nodes, and the patient did not have a cat or any history of contact, scratches, or bites by a cat. In our patient this infection resolved successfully with a combination of 2 associated antibiotics and reduction of immunosuppressive therapy.
MeSH terms
-
Amikacin / therapeutic use
-
Anti-Infective Agents / therapeutic use
-
Antibodies, Bacterial / blood
-
Azithromycin / therapeutic use
-
Bartonella henselae / isolation & purification*
-
Cat-Scratch Disease / diagnosis*
-
Cat-Scratch Disease / drug therapy
-
Cat-Scratch Disease / etiology
-
Cat-Scratch Disease / transmission
-
Child
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Liver / diagnostic imaging
-
Liver / microbiology
-
Liver / pathology
-
Liver Neoplasms / diagnosis*
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / etiology
-
Liver Neoplasms / microbiology
-
Liver Transplantation / adverse effects*
-
Lymph Nodes / diagnostic imaging
-
Lymph Nodes / microbiology
-
Lymph Nodes / pathology
-
Lymphomatoid Granulomatosis / diagnosis*
-
Lymphomatoid Granulomatosis / drug therapy
-
Lymphomatoid Granulomatosis / etiology
-
Lymphomatoid Granulomatosis / microbiology
-
Male
-
Postoperative Complications / diagnosis*
-
Postoperative Complications / etiology
-
Postoperative Complications / microbiology
-
RNA, Bacterial / analysis
-
RNA, Ribosomal, 16S / analysis
-
RNA, Ribosomal, 23S / analysis
-
Tacrolimus / administration & dosage
-
Tissue Donors
-
Transplants / microbiology
-
Treatment Outcome
-
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
-
Ultrasonography
Substances
-
Anti-Infective Agents
-
Antibodies, Bacterial
-
Immunosuppressive Agents
-
RNA, Bacterial
-
RNA, Ribosomal, 16S
-
RNA, Ribosomal, 23S
-
Trimethoprim, Sulfamethoxazole Drug Combination
-
Azithromycin
-
Amikacin
-
Tacrolimus